Imatinib
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Azienda Ospedaliera Universitaria Policlinico
Overview
Imatinib is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Imatinib clinical trials
Explore related
Medical disclaimer. This page summarizes research about Imatinib for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.